# Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rivaroxaban-s-impact-on-renal-decline-in-patients-with-nonvalvular-atrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Craig I Coleman,Reinhold Kreutz,Nitesh Sood,Thomas J. Bunz,Anna‐Katharina Meinecke,Daniel Eriksson,William L. Baker |
| Citations | 59 |
| DOI | 10.1177/1076029619868535 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.sagepub.com/doi/pdf/10.1177/1076029619868535 |
| OpenAlex ID | https://openalex.org/W2968377310 |
| PMID | 31392894 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Daniel Eriksson](https://scholariq.org/researchers/daniel-eriksson/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.